FDA GRANTS ORPHAN DRUG DESIGNATION FOR DROXIDOPA.: An article from: Biotech Business

This digital document is an article from Biotech Business, published by Thomson Gale on March 1, 2007. The length of the article is 1026 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: FDA GRANTS ORPHAN DRUG DESIGNATION FOR DROXIDOPA.
Author: Gale Reference Team
Publication:Biotech Business (Newsletter)
Date: March 1, 2007
Publisher: Thomson Gale
Volume: 20 Issue: 3 Page: NA

Distributed by Thomson Gale